Home

CytomX Therapeutics, Inc. - Common Stock (CTMX)

2.6000
+0.1100 (4.42%)
NASDAQ · Last Trade: Jul 11th, 3:02 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close2.490
Open2.500
Bid2.550
Ask2.750
Day's Range2.440 - 2.790
52 Week Range0.4000 - 3.095
Volume3,723,165
Market Cap173.60M
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume2,452,276

Chart

About CytomX Therapeutics, Inc. - Common Stock (CTMX)

CytomX Therapeutics is a biotechnology company focused on developing innovative cancer therapies through its proprietary Probody™ therapeutic technology. This platform is designed to selectively activate antibody-based treatments in the tumor microenvironment, helping to enhance the efficacy and reduce potential side effects of cancer therapies. CytomX is engaged in creating a pipeline of product candidates aiming to address various types of cancer, leveraging its expertise in protein engineering and immuno-oncology to advance treatment options and improve patient outcomes. The company collaborates with pharmaceutical partners to accelerate the development of its therapeutic candidates, with the goal of bringing novel, targeted therapies to market. Read More

News & Press Releases

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
NetworkNewsWire Editorial Coverage : Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease worldwide, a toll that is projected to rise in the coming decades. By 2050, the American Cancer Society estimates that annual cancer diagnoses will reach 35 million. While advances in treatment have improved outcomes for some patients, the demand for more effective therapies remains urgent — and the opportunity for innovation and market impact is significant. Calidi Biotherapeutics Inc. (NYSE American: CLDI) ( Profile ) is taking a bold approach to this challenge with a next-generation platform designed to deliver genetic medicines directly to both primary and metastatic tumors. Using engineered viruses to transport therapeutic payloads with precision, Calidi’s technology aims to transform the landscape of cancer treatment. Though oncology is its initial focus, the company is also exploring broader applications in high-need areas such as autoimmune disorders. In doing so, Calidi is positioning itself among a select group of biotech innovators, including Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), ImmunityBio Inc. (NASDAQ: IBRX) , Crispr Therapeutics AG (NASDAQ: CRSP) and…
Via Investor Brand Network · July 9, 2025
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
EQNX::TICKER_START (NYSE:CLDI),(NASDAQ:VRTX),(NASDAQ:IBRX),(NASDAQ:CRSP),(NASDAQ:CTMX) EQNX::TICKER_END
Via FinancialNewsMedia · July 9, 2025
CYTOMX THERAPEUTICS INC (NASDAQ:CTMX) - A Strong Contender in High-Growth Biotechchartmill.com
CYTOMX THERAPEUTICS (CTMX) meets Minervini’s trend criteria with strong technicals and high-growth fundamentals, making it a candidate for momentum investors.
Via Chartmill · July 8, 2025
Earnings Scheduled For May 12, 2025benzinga.com
Via Benzinga · May 12, 2025
Exploring CytomX Therapeutics's Earnings Expectationsbenzinga.com
Via Benzinga · May 9, 2025
Heico, Monro, Abercrombie & Fitch, Joby Aviation And Other Big Stocks Moving Higher On Wednesdaybenzinga.com
Via Benzinga · May 28, 2025
CytomX Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)benzinga.com
Via Benzinga · May 20, 2025
This CytomX Therapeutics Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursdaybenzinga.com
Via Benzinga · May 15, 2025
CytomX Stock Hits 2-Month High After Upbeat Q1 Earnings, Promising Early Data For Cancer Drugstocktwits.com
The company shared Phase 1 trial results for CX-2051, an antibody-drug conjugate for advanced colorectal cancer, with 28% of patients achieving confirmed partial responses.
Via Stocktwits · May 12, 2025
Top movers analysis one hour before the close of the markets on 2025-05-12: top gainers and losers in today's session.chartmill.com
Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · May 12, 2025
Monday's session: most active stockschartmill.com
These stocks are making the most noise in today's session. Stay tuned for the latest updates!
Via Chartmill · May 12, 2025
Stocks Under $1 to Watch: TAOP, WLGS, HIT, CTMX, JYD – Major Updates, Earnings & Offerings, More Inside….
Investors are closely monitoring several under-$1 Nasdaq-listed stocks delivering key updates and financial milestones this week:
Via AB Newswire · May 12, 2025
Which stocks are moving on Monday?chartmill.com
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via Chartmill · May 12, 2025
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · May 12, 2025
These stocks are gapping in today's sessionchartmill.com
In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.
Via Chartmill · May 12, 2025
Nano-Cap CytomX Therapeutics Stock Surges On Heels Of Cancer Data Reportbenzinga.com
CytomX reported early Phase 1 data for CX-2051 in advanced colorectal cancer, with a 94% disease control rate.
Via Benzinga · May 12, 2025
Top movers in Monday's pre-market sessionchartmill.com
Wondering what's happening in Monday's pre-market session? Find an overview in this article.
Via Chartmill · May 12, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 12, 2025
Wondering what's happening in today's pre-market session?chartmill.com
Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · May 9, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 9, 2025
These stocks are gapping in today's sessionchartmill.com
The market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill · May 5, 2025
Curious about the stocks that are showing activity after the closing bell on Monday?chartmill.com
The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.
Via Chartmill · April 28, 2025
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · April 28, 2025
Which stocks have an unusual volume on Monday?chartmill.com
Which stocks have an unusual volume on Monday?
Via Chartmill · March 10, 2025
Friday's pre-market session: top gainers and loserschartmill.com
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · March 7, 2025